CPT® Code 91302

Deleted

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10¹⁰ viral particles/0.5 mL dosage, for intramuscular use

The CPT® Code 91302 refers to a specific vaccine designed to provide immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for the disease known as COVID-19. This vaccine is classified as a viral vector vaccine, utilizing a non-replicating chimpanzee adenovirus vector, specifically the ChAdOx1 strain. The vaccine contains a dosage of 5x10¹⁰ viral particles in a 0.5 mL solution and is preservative-free, intended for intramuscular administration. The mechanism of action involves the delivery of genetic material that encodes the spike protein of the SARS-CoV-2 virus. Upon administration, the body’s immune system recognizes this spike protein as foreign, prompting the production of antibodies and memory cells that prepare the immune system to respond effectively to future exposures to the virus. This vaccine is specifically indicated for individuals aged 18 years and older and is reported solely for the supply of the vaccine itself. The actual administration of the vaccine is documented separately using the appropriate administration code, which varies based on the dosage given.